Has Steven Brown, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,348 in general payments to Steven Brown, MD across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Brown, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Brown, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Brown, MD

Colon & Rectal Surgery · Plainville, CTNPI 1871555771

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $745 and has fallen 78.8% since, to $158 in 2025.

$2,348in general payments, 2019–2025

Across 86 payments — averaging $27.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$494
Takeda Pharmaceuticals U.S.A., Inc.$383
Medtronic$224
Merz North America, Inc.$200
AbbVie$123
Bristol Myers Squibb$115
plus $809 from 16 others

What the payments were for

Speaking & faculty fees$1506%
Food & beverage$2,19894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	24	$494
Takeda Pharmaceuticals U.S.A., Inc.	12	$383
Medtronic	4	$224
Merz North America, Inc.	1	$200
AbbVie(2 entities)	6	$123
Bristol Myers Squibb	5	$115
Johnson & Johnson(2 entities)	4	$102
E.r. Squibb & Sons, L.L.C.	1	$99
Ironwood Pharmaceuticals, Inc	4	$97
Exact Sciences	4	$91
Ferring Pharmaceuticals Inc.	6	$88
Edwards Lifesciences	2	$58
Olympus America Inc.	2	$55
Regeneron Healthcare Solutions, Inc.	2	$43
Gilead	2	$39
KCI USA, Inc.	1	$29
Boston Scientific	1	$28
Pentax Of America, Inc.	1	$18
Masimo Corporation	1	$17
Braintree Laboratories, Inc.	1	$17
THD America, Inc.	1	$15
Micro-tech Endoscopy USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GATTEX$150
INTERSTIM$106

How this compares

$2,348 in reported general payments places this provider in the 60th percentile of 48 colon & rectal surgery providers in Connecticut.

See all colon & rectal surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024

$11,353

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	21	$1,188
Oxycodone Hcl	18	$97

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Plainville

John MonsonDanbury$182K
George YavorekNew Haven$45K
Nicole SaurFairfield$36K
Haddon PantelNew Haven$22K
Ryan BendlNorwalk$12K
Marc CasasantaDanbury$11K
Anne MongiuNew Haven$10K
Christine BartusNew Britain$9K
Sergio Casillas-RomeroNorwich$8K
Eric GirardFarmington$8K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →